Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.31 (
beta-glucuronidase
)
7,680
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The gusA gene, encoding a new
beta-glucuronidase
enzyme, has been cloned from Lactobacillus gasseri ADH. This is the first report of a
beta-glucuronidase
gene cloned from a bacterial source other than Escherichia coli. A plasmid library of L. gasseri chromosomal DNA was screened for complementation of an E. coli gus mutant. Two overlapping clones that restored
beta-glucuronidase
activity in the mutant strain were sequenced and revealed three complete and two partial open reading frames. The largest open reading frame, spanning 1,797 bp, encodes a 597-amino-acid protein that shows 39% identity to
beta-glucuronidase
(GusA) of E. coli K-12 (
EC 3.2.1.31
). The other two complete open reading frames, which are arranged to be separately transcribed, encode a putative
bile salt hydrolase
and a putative protein of unknown function with similarities to MerR-type regulatory proteins. Overexpression of GusA was achieved in a
beta-glucuronidase
-negative L. gasseri strain by expressing the gusA gene, subcloned onto a low-copy-number shuttle vector, from the strong Lactobacillus P6 promoter. GusA was also expressed in E. coli from a pET expression system. Preliminary characterization of the GusA protein from crude cell extracts revealed that the enzyme was active across an acidic pH range and a broad temperature range. An analysis of other lactobacilli identified
beta-glucuronidase
activity and gusA homologs in other L. gasseri isolates but not in other Lactobacillus species tested.
...
PMID:Identification and cloning of gusA, encoding a new beta-glucuronidase from Lactobacillus gasseri ADH. 1122 18
The bacterium Lactobacillus plantarum PH04 was isolated from infant feces and tested positive for bile/acid tolerance and
bile salt hydrolase
activity. It was evaluated as a potential probiotic with cholesterol-lowering effect. Bile salt hydrolase activity was nine times greater in stationary phase than in exponential phase cells and increased when the cells were exposed to conjugated bile salts. L. plantarum PH04 was resistant to seven of nine antibiotics tested and did not produce
beta-glucuronidase
. L. plantarum PH04 was fed to hypercholesterolemic mice at numbers of 10(7) CFU per mouse per day for 14 days. Compared with a control group, the serum cholesterol and triglycerides were respectively 7 and 10% lower in the group fed L. plantarum PH04, and fecal lactic acid bacteria increased while no any significant differences (P<0.05) in body weight, visceral weigh index or bacteria translocation between two groups were observed. The results indicated that L. plantarum PH04 might be effective as a probiotic with cholesterol-lowering activities.
...
PMID:Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects. 1714 Jun 90